Summary: Researchers demonstrated that the success of anti-CTLA-4 immunotherapy against brain tumors does not depend on local ...
Birds possess a specialized organ called the bursa of Fabricius that mammals do not have. It has long been thought that B ...
Researchers find that key antiviral proteins were unable to effectively combat the coronavirus in certain patients ...
Deep Origin docking software and molecular dynamics simulations pinpointed the lead compound from a 17-compound library ...
Fact check - The narrative mixes a number of scientific terms related to vaccines and then draws a false conclusion.
Researchers have uncovered a clue to why immune checkpoint inhibitors-cancer therapies that release the immune "brakes" exploited by tumors to evade attack-show limited efficacy in some brain tumors.
Ten-year results show a single CAR T infusion can keep many patients with aggressive and slow-growing B-cell lymphomas cancer-free, pointing toward true long-term cures.
Why do some vaccines protect for a lifetime, while threats like tumors and viruses present such an ongoing challenge? The ...
Low levels of replicating Epstein-Barr viruses might be the main driver of the autoimmune condition multiple sclerosis. This ...
Although the COVID-19 pandemic has largely subsided, scientists continue to investigate why the virus proved so deadly, ...
A connection between Epstein–Barr virus and MS has long been suspected, but the underlying mechanism was unclear until now.
Maharashtra CET Cell Extends BE/ B.Tech Registration Deadline To July 19, Releases Full CAP Schedule
Maharashtra CET Cell extended first-year BE/B.Tech admission registration deadline for 2026-27 to July 19, 5 pm. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results